Pneumococcal vaccination in patients with psoriasis or atopic dermatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017801

Enrollment

400

Registered

2019-08-26

Start date

2019-08-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L40.0 L20.0

Interventions

Group 1: Observational study: Patients with psoriasis or atopic dermatitis will complete a questionnaire on sociodemographic characteristics, disease characteristics, vaccinations and reasons for/agai

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Ability to consent - Signed and dated consent form - Patients with physician-diagnosed psoriasis or atopic dermatitis - Age: at least 18 years

Exclusion criteria

Exclusion criteria: Any member of the study team who is directly or indirectly involved in the study

Design outcomes

Primary

Measure	Time frame
The prevalence of pneumococcal vaccination among patients with Psoriasis and atopic dermatitis according to the vaccination certificate	—

Secondary

Measure	Time frame
Level of pneumococcal antibodies, Prevalence of further vaccinations, Individual reasons against vaccinations, Changes of vaccination and perceptions of vaccinations	—

Countries

Germany

Contacts

Public ContactRotraut Mößner

Universitätsmedizin Göttingen

rmoessn@gwdg.de0551-39-66401

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026